Evidence map›Paper›PMID 40399606›Full record

ArticleNature immunology2025

Bat organoids reveal antiviral responses at epithelial surfaces.

Max J Kellner, Vanessa M Monteil, Patrick Zelger, Gang Pei, Jie Jiao, Masahiro Onji, Komal Nayak, Matthias Zilbauer, Anne Balkema-Buschmann, Anca Dorhoi and 2 more

Abstract read
In one paragraph

Article in Nature immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Animal organoids as models for integrated One Health research.One health (Amsterdam, Netherlands) · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Mini bat organs reveal hidden viral threats.Clinical and translational medicine · 2025
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Max J KellnerInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna BioCenter (VBC), Vienna, Austria. maxjosef.kellner@helmholtz-hzi.de.ORCID http://orcid.org/0000-0002-5404-0628
Vanessa M MonteilDivision of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-2652-5695
Patrick ZelgerInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna BioCenter (VBC), Vienna, Austria.
Gang PeiInstitute of Immunology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.
Jie JiaoDepartment of Medical Genetics, Life Sciences Institute, University of British Columbia, Vancouver, British Columbia, Canada.ORCID http://orcid.org/0009-0009-7781-5762
Masahiro OnjiInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna BioCenter (VBC), Vienna, Austria.
Komal NayakWellcome - MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Matthias ZilbauerWellcome - MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0002-7272-0547
Anne Balkema-BuschmannInstitute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.
Anca DorhoiInstitute of Immunology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.ORCID http://orcid.org/0000-0003-1739-749X
Ali MirazimiDivision of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden.
Josef M PenningerInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna BioCenter (VBC), Vienna, Austria. josef.penninger@helmholtz-hzi.de.ORCID http://orcid.org/0000-0002-8194-3777

Funding

Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) 01KX2324EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 101005026Vetenskapsrådet (Swedish Research Council) 2018-05766
6 · The paper itself

Abstract

Bats can host viruses of pandemic concern without developing disease. The mechanisms underlying their exceptional resilience to viral infections are largely unresolved, necessitating the development of physiologically relevant and genetically tractable research models. Here, we developed respiratory and intestinal organoids that recapitulated the cellular diversity of the in vivo epithelium present in Rousettus aegyptiacus, the natural reservoir for the highly pathogenic Marburg virus (MARV). In contrast to human counterparts, bat organoids and mucosal tissue exhibited elevated constitutive expression of innate immune effectors, including type I interferon-ε (IFNε) and IFN-stimulated genes (ISGs). Upon infection with diverse zoonotic viruses, including MARV, bat organoids strongly induced type I and III IFN responses, which conferred robust antiviral protection. Type III IFNλ3 additionally displayed virus-independent self-amplification, acting as an ISG to enhance antiviral immunity. Our organoid platform reveals key features of bat epithelial antiviral immunity that may inform therapeutic strategies for viral disease resilience.

Indexed as

ChiropteraMarburgvirusOrganoidsAnimalsHumansImmunity, InnateInterferonsIntestinal MucosaRespiratory MucosaInterferons

Identifiers

PMID40399606
PMCPMC12133567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.